(Q35072272)

6 August 2017

1 reference

title

The expanding applications of non-myeloablative stem cell transplantation (English)

1 reference

6 August 2017

Thomas R Spitzer

1

1 reference

6 August 2017

publication date

1 January 2003

1 reference

Pediatric Transplantation

6 August 2017

published in

1 reference

6 August 2017

volume

7 Suppl 3

1 reference

6 August 2017

page(s)

95-100

1 reference

Mixed lymphohaemopoietic chimerism and graft-versus-lymphoma effects after non-myeloablative therapy and HLA-mismatched bone-marrow transplantation

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.7.S3.15.X

7 January 2021

Intentional induction of mixed chimerism and achievement of antitumor responses after nonmyeloablative conditioning therapy and HLA-matched donor bone marrow transplantation for refractory hematologic malignancies

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.7.S3.15.X

7 January 2021

Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.7.S3.15.X

7 January 2021

Lymphohematopoietic graft-vs.-host reactions can be induced without graft-vs.-host disease in murine mixed chimeras established with a cyclophosphamide-based nonmyeloablative conditioning regimen

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.7.S3.15.X

7 January 2021

Nonmyeloablative conditioning to induce bilateral tolerance after allogeneic bone marrow transplantation in mice

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.7.S3.15.X

7 January 2021

Induction of high levels of allogeneic hematopoietic reconstitution and donor-specific tolerance without myelosuppressive conditioning

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.7.S3.15.X

7 January 2021

Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.7.S3.15.X

7 January 2021

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.7.S3.15.X

7 January 2021

SELECTIVE DELETION OF ANTIGEN-SPECIFIC, ACTIVATED T CELLS BY A HUMANIZED MAB TO CD2 (MEDI-507) IS MEDIATED BY NK CELLS

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.7.S3.15.X

7 January 2021

Severe canine hereditary hemolytic anemia treated by nonmyeloablative marrow transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.7.S3.15.X

7 January 2021

Treatment of chronic granulomatous disease with nonmyeloablative conditioning and a T-cell-depleted hematopoietic allograft

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.7.S3.15.X

7 January 2021

Bone marrow transplantation for sickle cell disease.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.7.S3.15.X

7 January 2021

Bone marrow transplantation without myeloablation for sickle cell disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.7.S3.15.X

7 January 2021

Bone marrow transplantation in patients with thalassemia

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.7.S3.15.X

7 January 2021

Bone marrow transplantation for beta-thalassemia: the University of California San Francisco experience

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.7.S3.15.X

7 January 2021

Regression of Metastatic Renal-Cell Carcinoma after Nonmyeloablative Allogeneic Peripheral-Blood Stem-Cell Transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.7.S3.15.X

7 January 2021

Allogeneic peripheral-blood progenitor-cell transplantation for poor-risk patients with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.7.S3.15.X

7 January 2021

Transplantation tolerance prevents cardiac allograft vasculopathy in major histocompatibility complex class I-disparate miniature swine

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.7.S3.15.X

7 January 2021

Mixed chimerism and transplantation tolerance

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.7.S3.15.X

7 January 2021

10.1034/J.1399-3046.7.S3.15.X

Identifiers

DOI

1 reference

6 August 2017

1 reference